Membranous glomerulonephritis epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
| Line 6: | Line 6: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
* The membranous Glomerulonephritis is a rare disease.<ref name="pmid27365535">{{cite journal |vauthors=Xu X, Wang G, Chen N, Lu T, Nie S, Xu G, Zhang P, Luo Y, Wang Y, Wang X, Schwartz J, Geng J, Hou FF |title=Long-Term Exposure to Air Pollution and Increased Risk of Membranous Nephropathy in China |journal=J. Am. Soc. Nephrol. |volume=27 |issue=12 |pages=3739–3746 |date=December 2016 |pmid=27365535 |pmc=5118492 |doi=10.1681/ASN.2016010093 |url=}}</ref> <ref name="pmid24715030">{{cite journal |vauthors=Debiec H, Ronco P |title=Immunopathogenesis of membranous nephropathy: an update |journal=Semin Immunopathol |volume=36 |issue=4 |pages=381–97 |date=July 2014 |pmid=24715030 |doi=10.1007/s00281-014-0423-y |url=}}</ref> , <ref name="pmid28065518">{{cite journal |vauthors=Cattran DC, Brenchley PE |title=Membranous nephropathy: integrating basic science into improved clinical management |journal=Kidney Int. |volume=91 |issue=3 |pages=566–574 |date=March 2017 |pmid=28065518 |doi=10.1016/j.kint.2016.09.048 |url=}}</ref> | |||
===Incidence=== | ===Incidence=== | ||
*The incidence of membranous glomerulopathy is approximately 27 per 100,000 individuals worldwide. | *The incidence of membranous glomerulopathy is approximately 27 per 100,000 individuals worldwide. | ||
Revision as of 05:17, 17 July 2018
|
Membranous glomerulonephritis Microchapters |
|
Differentiating Membranous glomerulonephritis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Membranous glomerulonephritis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Membranous glomerulonephritis epidemiology and demographics |
|
FDA on Membranous glomerulonephritis epidemiology and demographics |
|
CDC on Membranous glomerulonephritis epidemiology and demographics |
|
Membranous glomerulonephritis epidemiology and demographics in the news |
|
Blogs on Membranous glomerulonephritis epidemiology and demographics |
|
Directions to Hospitals Treating Membranous glomerulonephritis |
|
Risk calculators and risk factors for Membranous glomerulonephritis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Epidemiology and Demographics
Incidence
- The incidence of membranous glomerulopathy is approximately 27 per 100,000 individuals worldwide.
- In 2002, the incidence of membranous glomerulopathy was estimated to be 27 cases per 100,000 individuals worldwide.
Prevalence
- The prevalence of membranous glomerulonephritis is approximately 690 per 100,000 individuals worldwide.
- In 2002, the prevalence of [disease name] was estimated to be 690 cases per 100,000 individuals worldwide.
Case-fatality rate/Mortality rate
- In 2001, the incidence of Membranous Glomerulonephritis is approximately 28.5 per 100,000 individuals with a case-fatality rate/mortality rate of 0.38%.
- The case-fatality rate/mortality rate of membranous glomerulonephritis is approximately 0.38%
Age
- Patients of all age groups may develop membranous glomerulonephritis.
- The incidence of Membranous Glomerulonephritis increases with age; the median age at diagnosis is 40 years.
- Membranous Glomerulonephritis commonly affects individuals older than 40 years of age.
Race
- membranous glomerulopathy usually affects individuals of the caucasian race.
Gender
- Membranous glomerulonephritis affects men and women equally.
Region
- Membranous glomerulonephritis tends to affect Caucasian population and Chinese population.
Developed Countries
Developing Countries
References
- ↑ Xu X, Wang G, Chen N, Lu T, Nie S, Xu G, Zhang P, Luo Y, Wang Y, Wang X, Schwartz J, Geng J, Hou FF (December 2016). "Long-Term Exposure to Air Pollution and Increased Risk of Membranous Nephropathy in China". J. Am. Soc. Nephrol. 27 (12): 3739–3746. doi:10.1681/ASN.2016010093. PMC 5118492. PMID 27365535.
- ↑ Debiec H, Ronco P (July 2014). "Immunopathogenesis of membranous nephropathy: an update". Semin Immunopathol. 36 (4): 381–97. doi:10.1007/s00281-014-0423-y. PMID 24715030.
- ↑ Cattran DC, Brenchley PE (March 2017). "Membranous nephropathy: integrating basic science into improved clinical management". Kidney Int. 91 (3): 566–574. doi:10.1016/j.kint.2016.09.048. PMID 28065518.